is hers still selling semaglutide Hims & Expands Personalized Weight Loss Portfolio with Access to Compounded Pills Starting at $49/Month* Novo sues Hims & Hers

Approval (2017) FDA News Release (March 8th, 2024): FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or Overweight FDA News Release (August 15th, 2025): FDA Approves Treatment for Serious Liver Disease Known as MASH OZEMPIC (semaglutide) injection, for subcutaneous use

It may also help with program comparisons

This strategy suits users who plateau after several months suggesting diminishing returns, want to minimize long-term costs while maintaining some benefits, prefer avoiding indefinite commitments to any treatment, notice maintained improvements during initial breaks suggesting cycling viability, and value flexibility over maximum continuous optimization

This anorexic response is largely mediated by neuronal areas within the hypothalamus and brainstem (189193)

The improvements to blood glucose could also be due to the enhancement of exercise performance, as exercise is known to be potent for improving blood sugar regulation

In line with multiple clinical practice guidelines, we recommend a patient-centered approach targeting diabetes-related cardiorenal comorbidities and risk factors, while considering the risk of adverse events, patient preference, and cost (Figure 1)